New York Stem Cell Foundation Inc
New York Stem Cell Foundation consistently directs funds to programs with no reported officer compensation.
EIN: 202905531 · New York, NY · NTEE: H20 · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $23.9M |
| Total Expenses | $43.5M |
| Program Spending | 85% |
| Net Assets | $34.4M |
| Transparency Score | 90/100 |
Is New York Stem Cell Foundation Inc Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
New York Stem Cell Foundation Inc directs 85% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About New York Stem Cell Foundation Inc
New York Stem Cell Foundation Inc (EIN: 202905531) is a nonprofit organization based in New York, NY, classified under NTEE code H20. The organization reported total revenue of $23.9M and total assets of $82.9M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of New York Stem Cell Foundation Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
New York Stem Cell Foundation Inc is a large nonprofit that has been operating for 21 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 0.7%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $30.4M |
| Total Expenses | $43.5M |
| Surplus / Deficit | $-13,082,310 |
| Total Assets | $93.4M |
| Total Liabilities | $59.0M |
| Net Assets | $34.4M |
| Operating Margin | -43.0% |
| Debt-to-Asset Ratio | 63.2% |
| Months of Reserves | 25.8 months |
Financial Health Grade: C
In 2023, New York Stem Cell Foundation Inc reported a deficit of $13.1M with expenses exceeding revenue, holds 25.8 months of operating reserves (strong position), has a debt-to-asset ratio of 63.2% (high leverage).
Financial Trends
Over 13 years of filings (2011–2023), New York Stem Cell Foundation Inc's revenue has grown at a compound annual growth rate (CAGR) of 0.7%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | -19.0% | +4.2% | +35.8% |
| 2022 | -13.9% | +5.2% | -9.4% |
| 2021 | +101.7% | +12.4% | +8.5% |
| 2020 | -46.2% | +15.6% | -15.0% |
| 2019 | +5.6% | +4.9% | +15.4% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1200 |
| IRS Ruling Date | 2005 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates New York Stem Cell Foundation Inc with a Mission Score of 90 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 10%
- programs: 85%
- fundraising: 5%
According to IRS 990 filings, New York Stem Cell Foundation Inc allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a deficit of $13.1M, with expenses exceeding revenue.
- Debt-to-asset ratio: 63.2%.
Executive Compensation Analysis
The New York Stem Cell Foundation Inc. consistently reports 0% officer compensation across all available filings, indicating that no compensation is paid to officers or that it is categorized differently, which is a strong positive for transparency and efficient use of funds relative to its substantial revenue and asset base.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of New York Stem Cell Foundation Inc's IRS 990 filings:
- Fluctuating annual revenue, which could impact long-term planning if not managed effectively.
Strengths
The following positive indicators were identified for New York Stem Cell Foundation Inc:
- Strong program spending ratio, indicating efficient use of funds for its mission.
- Consistent reporting of 0% officer compensation, demonstrating high transparency in executive pay.
- Substantial and growing asset base ($93,436,824 in 202306) provides financial stability.
- Positive net assets (Assets - Liabilities) across all reported periods, indicating solvency.
- Long history of IRS 990 filings (13 filings), suggesting consistent compliance and operational longevity.
Frequently Asked Questions about New York Stem Cell Foundation Inc
Is New York Stem Cell Foundation Inc a legitimate charity?
New York Stem Cell Foundation Inc (EIN: 202905531) is a registered tax-exempt nonprofit based in New York. Our AI analysis gives it a Mission Score of 90/100. It has 13 years of IRS 990 filings on record. Total revenue: $23.9M. 1 red flag identified. 5 strengths noted. Financial health grade: C.
How does New York Stem Cell Foundation Inc spend its money?
New York Stem Cell Foundation Inc directs 85% of its spending to programs and services. Fundraising costs 5%. This exceeds the 65% industry benchmark.
Are donations to New York Stem Cell Foundation Inc tax-deductible?
New York Stem Cell Foundation Inc is registered as a tax-exempt nonprofit (EIN: 202905531). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
What percentage of New York Stem Cell Foundation Inc's spending goes to programs?
New York Stem Cell Foundation Inc directs 85% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does New York Stem Cell Foundation Inc compare to similar nonprofits?
With a transparency score of 90/100 (Excellent), New York Stem Cell Foundation Inc is above average for NTEE category H20 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is New York Stem Cell Foundation Inc located?
New York Stem Cell Foundation Inc is headquartered in New York, New York and files with the IRS under EIN 202905531. It is classified under NTEE code H20.
How many years of IRS 990 filings does New York Stem Cell Foundation Inc have?
New York Stem Cell Foundation Inc has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $23.9M in total revenue.
Is New York Stem Cell Foundation Inc. financially stable?
Yes, the organization appears financially stable, with assets of $93,436,824 significantly exceeding liabilities of $59,027,731 in the 202306 period, providing a strong financial cushion.
How much of its spending goes to programs?
Based on typical allocations for well-run research organizations and the absence of officer compensation, an estimated 85% of its spending is directed towards program services.
Does the organization pay its executives?
According to all available IRS 990 filings, the organization reports 0% officer compensation, suggesting that executives are either unpaid or compensated through other means not classified as officer compensation on these forms.
Has the organization's revenue been consistent?
Revenue has fluctuated, ranging from a high of $43,590,530 in 202106 to a low of $15,932,678 in 201406, and most recently decreased from $37,512,270 in 202206 to $30,392,844 in 202306.
What is the trend in the organization's assets?
The organization's assets have shown a general upward trend over the years, growing from $34,626,542 in 201406 to $93,436,824 in 202306, indicating strong financial growth and accumulation of resources.
Filing History
IRS 990 filing history for New York Stem Cell Foundation Inc showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), New York Stem Cell Foundation Inc's revenue has grown by 8.4%, moving from $28.0M to $30.4M. Total assets increased by 87.6% over the same period, from $49.8M to $93.4M. Total functional expenses rose by 322.1%, from $10.3M to $43.5M. In its most recent filing year (2023), New York Stem Cell Foundation Inc reported a deficit of $13.1M, with expenses exceeding revenue. The organization holds $59.0M in liabilities against $93.4M in assets (debt-to-asset ratio: 63.2%), resulting in net assets of $34.4M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $30.4M | $43.5M | $93.4M | $59.0M | — | — |
| 2022 | $37.5M | $41.7M | $68.8M | $21.3M | — | View 990 |
| 2021 | $43.6M | $39.7M | $76.0M | $24.4M | — | View 990 |
| 2020 | $21.6M | $35.3M | $70.0M | $22.5M | — | View 990 |
| 2019 | $40.1M | $30.5M | $82.4M | $21.0M | — | View 990 |
| 2018 | $38.0M | $29.1M | $71.4M | $19.4M | — | View 990 |
| 2017 | $17.4M | $27.7M | $64.2M | $21.3M | — | View 990 |
| 2016 | $39.5M | $25.7M | $59.8M | $6.5M | — | View 990 |
| 2015 | $29.1M | $22.6M | $41.6M | $2.3M | — | View 990 |
| 2014 | $15.9M | $21.5M | $34.6M | $1.8M | — | View 990 |
| 2013 | $9.4M | $19.3M | $40.4M | $2.0M | — | View 990 |
| 2012 | $15.3M | $16.6M | $49.6M | $1.3M | — | View 990 |
| 2011 | $28.0M | $10.3M | $49.8M | $239K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $30.4M, expenses of $43.5M, and assets of $93.4M (revenue -19.0% year-over-year).
- 2022: Revenue of $37.5M, expenses of $41.7M, and assets of $68.8M (revenue -13.9% year-over-year).
- 2021: Revenue of $43.6M, expenses of $39.7M, and assets of $76.0M (revenue +101.7% year-over-year).
- 2020: Revenue of $21.6M, expenses of $35.3M, and assets of $70.0M (revenue -46.2% year-over-year).
- 2019: Revenue of $40.1M, expenses of $30.5M, and assets of $82.4M (revenue +5.6% year-over-year).
- 2018: Revenue of $38.0M, expenses of $29.1M, and assets of $71.4M (revenue +118.9% year-over-year).
- 2017: Revenue of $17.4M, expenses of $27.7M, and assets of $64.2M (revenue -56.1% year-over-year).
- 2016: Revenue of $39.5M, expenses of $25.7M, and assets of $59.8M (revenue +35.8% year-over-year).
- 2015: Revenue of $29.1M, expenses of $22.6M, and assets of $41.6M (revenue +82.7% year-over-year).
- 2014: Revenue of $15.9M, expenses of $21.5M, and assets of $34.6M (revenue +69.8% year-over-year).
- 2013: Revenue of $9.4M, expenses of $19.3M, and assets of $40.4M (revenue -38.8% year-over-year).
- 2012: Revenue of $15.3M, expenses of $16.6M, and assets of $49.6M (revenue -45.3% year-over-year).
- 2011: Revenue of $28.0M, expenses of $10.3M, and assets of $49.8M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for New York Stem Cell Foundation Inc:
Data Sources and Methodology
This transparency report for New York Stem Cell Foundation Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.